HMG-CoA reductase, cholesterol 7α-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia
- 1 July 2003
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 64 (1), 192-198
- https://doi.org/10.1046/j.1523-1755.2003.00041.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosisKidney International, 2003
- Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndromeKidney International, 2002
- Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failureKidney International, 2001
- Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndromeKidney International, 1999
- Amino Acid Residue 149 of Lecithin:Cholesterol Acyltransferase Determines Phospholipase A2 and Transacylase Fatty Acyl SpecificityPublished by Elsevier BV ,1997
- Down-regulation of hepatic LDL receptor expression in experimental nephrosisKidney International, 1996
- Gene expression of hepatic cholesterol 7α-hydroxylase in the course of puromycin-induced nephrosisKidney International, 1996
- Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosisKidney International, 1995
- Hyperlipoproteinemia in one-year-old analbuminemic ratsAtherosclerosis, 1991
- Analbuminaemia: a natural model of metabolic compensatory systemsJournal of Inherited Metabolic Disease, 1986